SPX4,026.12-1.14 -0.03%
DIA343.52+1.57 0.46%
IXIC11,226.36-58.96 -0.52%

JMP Securities Initiates Coverage On Spruce Biosciences with Market Outperform Rating, Announces Price Target of $8

Benzinga · 11/16/2022 06:17
JMP Securities analyst Jonathan Wolleben initiates coverage on Spruce Biosciences (NASDAQ:SPRB) with a Market Outperform rating and announces Price Target of $8.